Introduction
============

Bio-surgical debridement by calliphorid fly maggots was evolved in the 1920s \[[@R1]\]. With the improvement of surgical procedures and the implementation of novel antibiotic substances it got intermittently out of date since the 1940s \[[@R2]\], \[[@R3]\]. The method was re-introduced in 1988 for the treatment of chronic wounds \[[@R4]\], \[[@R5]\], \[[@R6]\], \[[@R7]\]. In face of the rising problems with multidrug-resistant pathogens due to antibiotic overuse the following decades it gained attention for its different modus operandi. Today it is an accredited method in the therapy of non-healing wounds.

Duration of maggot use (i.e. contact of larvae to the wound) is with bio-bags 3--4 days and with free-range larvae (50--400 maggots per treatment) 1--2 days \[[@R8]\], \[[@R9]\]. Following the treatment the bio-bags or the free-range larvae are disposed in trash-bags. The manufacturers do not give any recommendations on how to eliminate the maggots before disposal. Hence escaping larvae, which can be regularly observed using the free-range method, could reach other possibly not infected wounds of the treated patient or his/her direct environment or different hygiene sensitive areas in the hospital. Maggots are able to excrete viable pathogens such as methicillin-susceptible (MSSA) and methicillin-resistant *Staphylococcus aureus* (MRSA), which were ingested up to 48 h prior to excretion, as seen in a prior in vitro study, underscoring the potential role of used maggots as pathogen reservoir in hospitals \[[@R10]\]. Four cases of bloodstream infections with *Providencia stuartii* and one with *Candida albicans* were reported during maggot therapy, however, the blood isolates could be traced back to contaminated maggots of the species *Protophormia terraenovae*. The disinfecting procedure of the maggots was optimized and no case of sepsis occurred in 45 patients treated thereafter \[[@R11]\].

Accordingly, maggots used in debridement therapy must be regarded as potential reservoir and vector for pathogens and should be inactivated before disposal. Common practice in many hospitals is freezing the used larvae for an undetermined time-span at --20°C (as a disinfection procedure is not necessary for used wound dressings) to solve the obvious problem with these biological dressings of being able to move.

The aim of this work was to demonstrate the excretion of viable bacteria by maggots after ingestion and cuticula contamination and to evaluate the freezing method for inactivation of used maggots before disposal.

Material and methods
====================

Maggots
-------

The sterile maggots belonged to the species *Lucilia sericata*; *Diptera*: *Calliphoridae* (Biomonde GmbH, Barsbüttel, Germany). After visual examination and following incubation (48 h at 37°C on sterile Columbia agar plates with 5% sheep blood \[Oxoid, Wesel, Germany\]) they were used for the experiments in the third larval stage.

Bacteria
--------

Bacteria used in this study included a methicillin-susceptible strain of *Staphylococcus aureus* (MSSA, ATCC 6538, American Type Culture Collection, Manassas, Va., USA). All other used strains (*Escherichia coli*, *Enterococcus faecium*, *Pseudomonas aeruginosa*, *Proteus mirabilis*, *Klebsiella pneumoniae*, and methicillin-resistant strain of *Staphylococcus aureus* (MRSA)) were isolated from acute or chronic wounds of patients of our clinic during routine microbiology diagnostics or in the course of MRSA surveillance (admission screen for multidrug-resistant strains). Each strain was isolated from a different patient. Samples were processed following the national guidelines for microbiologic diagnostics. Identification and susceptibility testing were performed using the automated VITEKcompact system (Biomérieux, Nürtingen, Germany).

Contamination of maggots with bacteria (MSSA)
---------------------------------------------

Ten maggots about 5 mm long and 3 mm in diameter were contaminated with MSSA by allowing them to crawl over an agar surface completely covered with bacterial growth over 24 h at 37°C. During exposition, all larvae (one per 90 mm agar plate) were monitored showing permanent crawling movements facing the complete agar surface and leaving deep spurs all over the agar surface caused by ingestion of bacterial colonies. Thereafter, the exterior of maggots was disinfected with 70% ethanol and exposure of 5 min. The larvae were rolled over ethanol-wetted paper towels with close contact of the complete larval cuticula (the larval disinfection was experienced in prior studies, where contact plates could show effective disinfection after 5 min exposure). The decontaminated maggots (control contact plates from each maggot did not show bacterial growth after 72 h, data not shown) were then transferred onto sterile Columbia agar plates for additional 24 h in order to visualize the shedding of bacteria by maggots. Additionally, 3 maggots prepared likewise were dissected (cut in tranches) and the tranches were put onto sterile Columbia agar plates.

Maggot inactivation by freezing
-------------------------------

To analyze deep freezing as inactivation tool of used maggots, maggots (10 larvae each) were frozen at --20°C for 1, 2, 5, 10, 30 and 60 min in sterile tubes (10 ml, Sarstedt, Germany). After exposure, the frozen larvae were transferred onto Columbia blood agar with consecutive incubation at 37°C over 48 h. The larvae were analyzed visually for mobility and eating activities.

The same assay was performed with 5 larvae, which have been fed over 24 h on Columbia agar with colonies of *S. aureus* (MSSA), twelve fresh maggots contaminated with *E. coli*, *E. faecium*, *P. aeruginosa*, *K. pneumoniae*, *P. mirabilis*, and MRSA (2 maggots for each species) overnight by the same way, and five maggots taken from heavily microbial colonized chronic wounds (with *P. aeruginosa* and *P. mirabilis*) in which they had fulfilled their debridement activity. The frozen bodies of these larvae were examined for viable bacteria. This was executed by grinding the frozen bodies, streaking the obtained maggot powder onto Columbia blood agar and enumerating bacterial colonies after 24 h incubation (37°C) grown on the agar.

Results
=======

Contamination of maggots with bacteria (MSSA)
---------------------------------------------

All ten maggots exposed to MSSA on agar were shown to shed viable MSSA. The MSSA appeared as whitish spurs covering the agar surface with the pathogen after 24 h incubation (Figure 1 [(Fig. 1)](#F1){ref-type="fig"}). Consecutively performed transversal cutting of three maggots revealed abundant staphylococcal growth (\>10 CFU per tranche), showing that larvae of *L. sericata* are able to release viable MSSA, which were formerly ingested.

Maggot inactivation by freezing
-------------------------------

Freezing at --20°C for up to 30 min did not substantially affect the maggot's vitality as shown by nearly unaffected viability of all maggots some minutes after thawing. Freezing for at least 60 min successfully killed all larvae (no mobility over 72 h after removal from freezer, data not shown).

The ingested bacteria of all tested species (MSSA, MRSA, *P. aeruginosa*, *P. mirabilis*, *E.coli*, *Klebsiella pneumoniae*, *E. faecium*) from the experimentally contaminated maggots and from the in real biosurgery contaminated as well, stayed active as anticipated, showing extensive growth on agar plates (data not shown).

Discussion
==========

The good results of maggot debridement therapy were commonly explained with controlled myiasis (i.e. debridement of necrotic tissue), stimulated tissue granulation \[[@R12]\], and secretion of antibacterial proteins \[[@R13]\]. Shortly after introduction of maggot debridement therapy by Baer in 1931 \[[@R1]\], the presence of an antibacterial substance in the body and secretions of *L. sericata* was demonstrated by Weil et al. \[[@R14]\] and since then the presence of several specific peptides with antibacterial activity, either in the body or the secretions of maggots were described \[[@R15]\], \[[@R16]\], \[[@R17]\]. The authors' recent work showed that maggot secretion fulfills the definitions of an antiseptic and already small amount of larvae strongly affect bacteria \[[@R10]\]. Maggot excretions supposedly are free of bacteria as elimination of bacteria in the digestive tract to almost zero is described \[[@R18]\], \[[@R19]\]. In contrast, the authors' recent work showed that ingested strains of MSSA and MRSA were excreted to the environment and even remained vital within the pupa \[[@R10]\]. However, other studies demonstrated that maggots of *L. sericata* are not able to eliminate equally well different Gram+ and Gram-- bacteria \[[@R15]\], \[[@R16]\], \[[@R17]\], \[[@R20]\].

Despite their antibacterial activities, maggots themselves remain contaminated with bacteria (most probably around their mouthparts) and they are able to shed them to the environment (most probably together with their saliva). Accordingly, under certain circumstances and for given bacteria (i.e. MRSA and extended-spectrum beta-lactamase Gram-negative bacteria), maggots might serve as vectors of germ transmission, especially when they escape from the wound or are actively removed from wounds at the end of the bio-debridement therapy, without being properly disposed as clinical waste. The data at hand show that larvae ingest and release MSSA, even several days after stopping ingestion. Other bacteria may follow this way as it was shown for *P. mirabilis* and *P. aeruginosa* cultured from larvae, which were removed from patient's wound, and for *K. pneumoniae*, *E. coli*, *E. faecium*, *P. aeruginosa*, and MRSA after artificial contamination. Accordingly, maggots separated from contaminated wounds are able to transfer wound pathogens to their environment by direct contact (body contamination) and indirectly by shedding viable pathogens. On the other hand, recontamination or infection of already cleansed wounds or wounds under debridement via contaminated maggots is possible. This risk should be focused by adequate measures: one could be antiseptic wound treatment in parallel to the maggot therapy, which until now not has been described and would be desirable in particular for expected cumulative beneficial effects. Another measure could be establishment of reliable de-waste procedures.

As for delineation of potential methods for safe inactivation of used maggots before disposal together with potentially viable ingested pathogens only freezing over at least 60 min at --20°C caused the death of all maggots, however the *in vitro* or on patient's wound ingested bacteria were still viable. Therefore, the authors recommend disposal of free range maggots in closed vials (screw cap) and regard them as biological waste. Bio-bags can be discarded in normal trash-bags if the bio-bag is completely intact. A possible alternative may be inactivation of colonizing pathogens in parallel with maggot activity in the wounds when it can be demonstrated that antisepsis is not harming maggot activity. This is currently under investigation.

Conclusions
===========

Used larvae should be regarded as biological waste and potentially will carry and spread multiple and multi-drug resistant pathogens.Maggots can easily survive freezing for up to 30 minutes at --20°C. They can be killed when exposed over 60 min but preserve vital pathogens inside their body. The disposal of free-range larvae into screw capped vials easily achieves full hygienic control.Bio-bags should get visually examined for intactness before disposal in normal trash-bags.

Notes
=====
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